What Is Photodynamic Therapy?

Photodynamic therapy (PDT) is a clinical treatment modality that uses the combined action of a photosensitizing agent, a specific wavelength of light, and molecular oxygen to selectively destroy targeted tissue. The therapy exploits a photochemical reaction: when light of the appropriate wavelength activates the photosensitizer, the excited molecule transfers energy to surrounding oxygen, generating reactive oxygen species that are cytotoxic to the target cells. Because the reaction requires all three components simultaneously, PDT can be applied with spatial precision by directing light only to the intended tissue.

PDT draws on photochemistry, photobiology, and clinical medicine. The photosensitizer is typically administered systemically or topically and preferentially accumulates in abnormal or rapidly proliferating cells, providing a degree of inherent selectivity before light is even applied. The technique was first explored in the early twentieth century and entered routine clinical practice for several oncological indications in the 1990s.

Photosensitizers

The photosensitizer is the central agent in PDT. First-generation compounds, such as porfimer sodium (Photofrin), are porphyrin-based molecules activated by red light near 630 nm. Second-generation agents, including 5-aminolevulinic acid (5-ALA) and its ester methyl aminolevulinate (MAL), are prodrugs that the body converts intracellularly into the active photosensitizer protoporphyrin IX. The StatPearls clinical review of photodynamic therapy notes that topical MAL-PDT achieves complete response rates of approximately 90% for actinic keratosis following two treatment sessions. Third-generation photosensitizers under development incorporate nanocarrier delivery systems to improve tumor targeting and reduce off-target photosensitivity.

Reactive Oxygen Species and Photochemical Mechanisms

Upon light absorption, the photosensitizer transitions to an excited singlet state and then undergoes intersystem crossing to a longer-lived triplet state. From the triplet state, two competing reaction pathways operate. Type I reactions involve direct electron or hydrogen transfer to substrate molecules, generating free radical intermediates that subsequently react with oxygen to form superoxide, hydroxyl radicals, and hydrogen peroxide. Type II reactions involve direct energy transfer from the triplet photosensitizer to ground-state molecular oxygen, producing singlet oxygen, which is highly reactive and the primary cytotoxic species in most clinical photosensitizers. Research published in reviews on reactive oxygen species in photodynamic cancer therapy demonstrates that singlet oxygen has a diffusion radius of roughly 20 nm in biological tissue, which confines damage to the immediate cellular environment of the photosensitizer.

Light Delivery and Dosimetry

The therapeutic outcome depends on precise light delivery. Red and near-infrared wavelengths in the range of 630–850 nm penetrate tissue most deeply, because hemoglobin and water absorb less at these wavelengths. Laser sources coupled to fiber optic applicators allow illumination of internal cavities, endoscopically accessible lumens, and surgically exposed tissue. Surface lesions may be treated with non-coherent LED arrays, which provide uniform fluence over large areas. Dosimetry accounts for fluence rate, total light dose, oxygen availability, and photosensitizer concentration to optimize the reactive oxygen yield while minimizing damage to adjacent healthy tissue. The Frontiers review on PDT in medical practice outlines how personalized dosimetry protocols have improved clinical outcomes across multiple anatomical sites.

Applications

Photodynamic therapy has applications across a range of medical disciplines, including:

• Dermatology: treatment of actinic keratoses, basal cell carcinoma, and Bowen disease
• Head and neck oncology: management of superficial tumors and pre-malignant lesions
• Gastroenterology: ablation of Barrett's esophagus and early esophageal carcinoma
• Ophthalmology: treatment of choroidal neovascularization in age-related macular degeneration
• Antimicrobial therapy: inactivation of bacteria, fungi, and biofilms in wound care